- FDA approves Regeneron's antibody for rare immune disease, resolves manufacturing issues for aflibercept Endpoints News
- FDA approves palovarotene capsules to treat fibrodysplasia ossificans progressiva Contemporary Pediatrics
- US FDA approves Regeneron's ultra-rare blood disease drug Reuters.com
- After much trial and error, Ipsen scores FDA nod for Sohonos FiercePharma
- FDA Approves Ipsen’s Palovarotene for Ultra-Rare Bone Disease BioSpace
- View Full Coverage on Google News
Friday, August 18, 2023
FDA approves Regeneron's antibody for rare immune disease, resolves manufacturing issues for aflibercept - Endpoints News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment